Compare JANX & REF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JANX | REF |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2021 | 2026 |
| Metric | JANX | REF |
|---|---|---|
| Price | $10.13 | $18.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 9 |
| Target Price | ★ $33.14 | $20.50 |
| AVG Volume (30 Days) | ★ 946.4K | 518.5K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,000,000.00 | N/A |
| Revenue This Year | $174.21 | $20.57 |
| Revenue Next Year | N/A | $16.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.16 | $11.85 |
| 52 Week High | $35.34 | $20.57 |
| Indicator | JANX | REF |
|---|---|---|
| Relative Strength Index (RSI) | 25.34 | 56.24 |
| Support Level | N/A | $12.55 |
| Resistance Level | $14.47 | $20.55 |
| Average True Range (ATR) | 1.16 | 1.48 |
| MACD | -0.48 | -0.01 |
| Stochastic Oscillator | 0.33 | 55.93 |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Reformation Inc sells apparel and accessories through its website, company-owned retail stores, wholesale channels, and other distribution channels in the United States and internationally. Its product portfolio includes dresses, bottoms, tops, sweaters, and accessories. The company focuses on womenswear and sources materials and products through its supply chain operations. The majority of the company's revenue was derived from the sale of its apparel and accessories, including clothing, shoes, and bags, through e-commerce and retail. Geographically, the maximum revenue is generated from the United States.